PDCD1 and hepatocellular carcinoma: By measuring the POSTN levels in paired serum samples from advanced HCC patients before and after PD‐1 immunotherapy, it was found that POSTN expression was lower before treatment and significantly increased after immunotherapy (Figure S8, Supporting Information).